Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling
dc.contributor.author | Ruwanpathirana, T. | |
dc.contributor.author | Owen, A. | |
dc.contributor.author | Renzaho, A. | |
dc.contributor.author | Zomer, E. | |
dc.contributor.author | Gambhir, M. | |
dc.contributor.author | Reid, Christopher | |
dc.date.accessioned | 2017-01-30T11:41:26Z | |
dc.date.available | 2017-01-30T11:41:26Z | |
dc.date.created | 2015-06-17T20:00:40Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Ruwanpathirana, T. and Owen, A. and Renzaho, A. and Zomer, E. and Gambhir, M. and Reid, C. 2015. Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling. Clinical and Experimental Pharmacology and Physiology. 42 (6): pp. 596-601. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/14094 | |
dc.identifier.doi | 10.1111/1440-1681.12399 | |
dc.description.abstract |
The study was designed to model the effectiveness and cost effectiveness of oral Vitamin D supplementation as a primary prevention strategy for cardiovascular disease among a migrant population in Australia. It was carried out in the Community Health Service, Kensington, Melbourne. Best-case scenario analysis using a Markov model was employed to look at the health care providers’ perspective. Adult migrants who were vitamin D deficient and free from cardiovascular disease visiting the medical centre at least once during the period from 1 January 2010 to 31 December 2012 were included in the study. The blood pressure-lowering effect of vitamin D was taken from a published meta-analysis and applied in the Framingham 10 year cardiovascular risk algorithm (with and without oral vitamin D supplements) to generate the probabilities of cardiovascular events. A Markov decision model was used to estimate the provider costs associated with the events and treatments. Uncertainties were derived by Monte Carlo simulation. Vitamin D oral supplementation (1000 IU/day) for 10 years could potentially prevent 31 (interquartile range (IQR) 26 to 37) non-fatal and 11 (IQR 10 to 15) fatal cardiovascular events in a migrant population of 10 000 assuming 100% compliance. The provider perspective incremental cost effectiveness per year of life saved was AU$3,992 (IQR 583 to 8558). This study suggests subsidised supplementation of oral vitamin D may be a cost effective intervention to reduce non-fatal and fatal cardiovascular outcomes in high-risk migrant populations. | |
dc.publisher | Wiley-Blackwell Publishing Asia | |
dc.subject | framingham risk score | |
dc.subject | cardiovascular disease | |
dc.subject | vitamin D deficiency | |
dc.subject | markov models | |
dc.title | Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling | |
dc.type | Journal Article | |
dcterms.source.volume | 42 | |
dcterms.source.number | 6 | |
dcterms.source.startPage | 596 | |
dcterms.source.endPage | 601 | |
dcterms.source.issn | 03051870 | |
dcterms.source.title | Clinical and Experimental Pharmacology and Physiology | |
curtin.accessStatus | Fulltext not available |